title: Stent fracture and restenosis in the drug-eluting stent era.
authors.affiliation: Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
authors.forename: Georgios
authors.initials: G
authors.lastname: Sianos
authors.forename: Sjoerd
authors.initials: S
authors.lastname: Hofma
authors.forename: Jurgen M R
authors.initials: JM
authors.lastname: Ligthart
authors.forename: Francesco
authors.initials: F
authors.lastname: Saia
authors.forename: Angela
authors.initials: A
authors.lastname: Hoye
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Lemos
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003324:Coronary Artery Disease / Q000628:therapy; D023903:Coronary Restenosis / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015918:Infusion Pumps, Implantable / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011475:Prosthesis Failure; D019919:Prosthesis Implantation / Q000009:adverse effects; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus